Filimon, Adriana
2 papers on CoChat
Most cited papers
- Verified
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato, S., Kahn, S. E., Pavo, I., Weerakkody, G. J., Yang, Z., Doupis, J., Aizenberg, D., Wynne, A. G., Riesmeyer, J. S., Heine, R. J., et al. (2021) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 684
- Verified
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine
Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension
Cited by 109
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free